Van de Put said in an interview with Food Dive that GLP-1 drugs could cut into product volumes at Mondelz by up to 1.5% by 2035
Until Wegovys MASH indication, patients with F2F3 fibrosis lacked any FDAapproved pharmacologic therapy targeting steatohepatitis resolution and fibrosis improvement, relying primarily on lifestyle modification and bariatric surgery. Against this background, semaglutides ability to deliver sustained doubledigit percentage weight loss, improve cardiometabolic markers, reduce MACE, and favorably modify histologic endpoints in MASH positions Wegovy as a versatile agent across cardiometabolic care pathways, provided its risks and limitations are fully understood and respected
How These Treatments Are Used Together in Weight Management Some private clinics discuss combining Lipo C with retatrutide to support hepatic fat metabolism alongside appetite reduction, but no clinical evidence or regulatory guidance supports this combination, and it should not be used outside approved clinical trials
The dosage of semaglutide used in this study (0.2 mg/kg/day) is based on extrapolations from human dosages
The Role of Medical Supervision Weight loss injections are prescribed within medical care because they influence more than appetite alone
The surgeon can do different things depending on what you want, ranging from cutting off excess tissue to reconstructing and sewing up different parts to inserting filler like fat